Global Cervical Cancer Screening Stays Low
A new study reveals that only 35% of women worldwide underwent cervical cancer screening in 2022.
Updated on Oct. 20, 2026 in Cancer
Live Poll
Should nations prioritize increasing global access to preventive cancer screenings for all citizens?
In 2022, only 35% of women aged 30-49 globally received cervical cancer screenings, highlighting significant disparities in healthcare access. High-income regions saw 74% coverage, while low- and middle-income countries reported just 26%.
Why it matters
Effective screening is essential for the early detection and treatment of precancerous lesions before they develop into cancer. The World Health Organization aims to eliminate the disease as a public health problem by increasing coverage rates.
A global study found that 35% of women underwent screening in 2022, with only 8% receiving HPV testing. Coverage varied starkly by region, from 80% in Australia and New Zealand down to 7% in Central and Southern Asia.
The players
World Health Organization
This is a specialized agency of the United Nations responsible for international public health.
The details
Researchers analyzed screening data across 202 countries and territories to evaluate current progress. While the World Health Organization prioritizes HPV testing to identify at-risk women, only 20 countries had fully implemented such programs by 2022.
Timeline
2022 was the year global screening coverage was estimated.
92 countries recommended HPV-based screening by 2025.
2030 is the target year for the World Health Organization to reach 70% screening coverage.
The Big Picture
This study provides a critical assessment of progress relative to the WHO's global strategy to accelerate the elimination of cervical cancer. It marks a check on international efforts to reduce mortality through increased standardized testing.
Women aged 30-49 should discuss local screening availability and HPV testing options with their healthcare providers to ensure early detection. Understanding these disparities encourages proactive advocacy for improved diagnostic access in underserved communities.
The takeaway
Early detection remains the most effective tool for preventing the progression of cervical cancer. Regular screening, especially through HPV testing, significantly improves health outcomes for women worldwide.
Further reading
Learn more about the latest developments and statistics in Cancer.
Source note: This article includes information reported by Biotech-spain.
Live Poll
Should nations prioritize increasing global access to preventive cancer screenings for all citizens?
